Cited by 694Angiogenesis and VEGF in CancerTGF-β signaling in diseasesLymphatic System and Diseases

Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.

Open access
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., Alitalo, K.·1994·Journal of Biological Chemistry

Abstract

Transforming growth factor beta (TGF-beta) is a multifunctional polypeptide that regulates the proliferation and differentiation of various cells and has an angiogenic effect in vivo, although it inhibits the growth of cultured endothelial cells. We report here that TGF-beta treatment of quiescent cultures of mouse embryo-derived AKR-2B cells, which are growth-stimulated by TGF-beta, and human lung adenocarcinoma A549 cells, which are growth-inhibited by TGF-beta, results in the induction of vascular endothelial growth factor (VEGF) mRNA and protein. Maximal VEGF mRNA levels occurred 4-8 h after stimulation with a decline to background levels in 24 h. In contrast, the related placenta growth factor mRNA was not induced by TGF-beta in these cells. No VEGF receptor mRNA was seen in AKR-2B cells. Also, TGF-beta treatment of endothelial cells, which express the FLT1 and KDR/FLK-1 receptors for VEGF, did not cause VEGF induction. Because VEGF is known to be a strong angiogenic factor for endothelial cells, the results suggest that the angiogenic effect of TGF-beta on endothelial cells in blood vessels may be mediated at least partly by a paracrine induction of VEGF in other surrounding cell types.

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(17)37365-9

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pro-angiogenic activities of TGF-β on endothelial cells are mediated by the ALK1 type I receptor and endoglin, which promote endothelial cell proliferation and migration.

    “Pro-angiogenic activities of TGF-β on endothelial cells are mediated by the ALK1 type I receptor and endoglin, which promote endothelial cell proliferation and migration265”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [265]

  • Various observations highlight activities of TGF-β on endothelial cells that may promote or repress angiogenesis, depending on the experimental setting.

    “Various observations highlight activities of TGF-β on endothelial cells that may promote or repress angiogenesis, depending on the experimental setting264–266.”

    From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [265]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K.
Affiliations
University of Helsinki (FI)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1994-03
Volume
269
Issue
9
Pages
6271-6274
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1494416455
Cited by
694
References
38
Citations by year
2025: 4 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 9 · 2015: 13 · 2014: 20 · 2013: 16 · 2012: 25
FWCI
10.52
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords
vascular endothelial growth factor, TGF-beta, angiogenesis, paracrine signaling, placental growth factor, VEGF receptors, Flt-1, KDR/Flk-1, A549 cells, lung adenocarcinoma, endothelial cells, fibroblasts, epithelial cells, VEGF mRNA expression
MeSH terms
Animals, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Epithelium, Fibroblasts, Humans, Hybrid Cells, Lung Neoplasms, Lymphokines, Mice, Inbred AKR, Recombinant Proteins, Tumor Cells, Cultured, Umbilical Veins, Immunoblotting, Transforming Growth Factor beta, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review